- The growing preference for oral solid dosage forms, such as tablets and capsules, is driving the demand for sugar-based excipients.
- These excipients enhance drug stability, bioavailability, and patient compliance through improved taste masking and ease of swallowing.
- The pharmaceutical industry is increasingly adopting co-processed excipients to improve the functionality of drug formulations.
- These excipients offer enhanced properties like better flowability, compressibility, and solubility, leading to more efficient and patient-friendly drug delivery systems.
Frequently Asked Questions
Germany is expected to dominate the global Sugar Based Excipients market, particularly in the Europe region. This dominance is attributed due to presence of major excipient producers such as Roquette Group (France), DFE Pharma (Germany), and BASF SE (Germany) enhances Europe's market position through advanced research and development capabilities.
Europe is expected to dominate the global Sugar Based Excipients market due to significant demand for sugar-based excipients used in oral formulations, including paediatric and geriatric medications.
China is expected to witness the highest CAGR in the Sugar Based Excipients market. This growth is driven by growing population, rising healthcare expenditure, and expanding pharmaceutical industries contribute to the demand for sugar-based excipients.
The primary challenges include stringent regulatory compliance.
The actual sugars segment is expected to dominate the global sugar based excipients market holding a major market share in 2025, due to their widespread use is attributed to their non-toxic nature, excellent taste-masking properties.
